Post-COVID-19 reactive arthritis.

Clin Rheumatol

Department of Rheumatology, Military Hospital, 1007, Tunis, Tunisia.

Published: August 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253246PMC
http://dx.doi.org/10.1007/s10067-022-06241-9DOI Listing

Publication Analysis

Top Keywords

post-covid-19 reactive
4
reactive arthritis
4
post-covid-19
1
arthritis
1

Similar Publications

Omics-based analysis of mitochondrial dysfunction and BBB integrity in post-COVID-19 sequelae.

Sci Rep

December 2024

Cell and Developmental Biology Laboratory, Research and Development Cell, PIMSR, Parul University, Vadodara, Gujarat, 391760, India.

The SARS-CoV-2 virus that resulted in the COVID-19 pandemic has been implicated in a range of neurological issues, such as encephalopathy, stroke, and cognitive decline. Although the precise mechanism causing these issues is unknown, mounting evidence shows that blood-brain barrier (BBB) disruption is probable2 a major factor. The integrity of the blood-brain barrier (BBB), a highly selective barrier that divides the brain from the systemic circulation, is crucial for preserving normal brain function.

View Article and Find Full Text PDF

Changing Epidemiology of Myocarditis in Australia: A Population-Based Cohort Study.

J Clin Med

November 2024

Department of Cardiology, Concord Hospital, The University of Sydney, 1 Hospital Road, Concord, Sydney, NSW 2139, Australia.

: Myocarditis is a serious disease that has drawn increasing attention due to its association with COVID-19 and vaccination. This study investigates the epidemiology of myocarditis beyond the COVID-19 pandemic, including its incidence and outcomes over time. : We analyzed the population-wide retrospective data from the Admitted-Patient-Data-Collection database of patients admitted to hospitals in New South Wales (NSW), Australia, with a diagnosis of myocarditis from 2001 to 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to explore the long-term impacts of COVID-19 on key vascular structures and clinical outcomes in individuals who had the virus.
  • Conducted at a post-COVID-19 clinic, the trial involved 72 post-COVID patients and 11 control participants, with follow-up assessments at 3, 6, and 12 months post-diagnosis.
  • Results indicated increased median intima-media thickness (IMT) in COVID-19 patients compared to controls, changes in blood cell markers and responses based on severity of infection, but no instances of deep vein thrombosis were found.
View Article and Find Full Text PDF

Mucormycosis is a rare but potentially fatal angioinvasive fungal infection, caused by filamentous molds of the order Mucorales, which primarily affects immunocompromised individuals and is characterized by high mortality rates. Diabetes mellitus (DM) is the most common risk factor for mucormycosis. During the COVID-19 pandemic, the number of cases significantly increased.

View Article and Find Full Text PDF

As the harm of benzalkyl dimethylammonium compounds (BACs) on human health and environment was discovered, alkyltrimethyl ammonium compound (ATMAC) and dialkyldimethyl ammonium compound (DADMAC), which belong to quaternary ammonium compounds (QACs), were likely to replace BACs as the main disinfectants. This study simulated the iterative use of QACs to explore their impact on resistance genes (RGs) in nitrification systems pre-contaminated by BACs. ATMAC could initiate and maintain partial nitrification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!